Impact of Antiglycemic & Immunosuppressive Therapies on NETosis in Diabetes & Kidney Disease (NETs - Neutrophil Traps)

IsraelRecruiting

Conditions

Diabetes Mellitus · Kidney Disease

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Galilee Medical Center, Nahariya, Israel
Contact: Study coordinator (Etty Kruzel-Davila, MD) · ETTYK@gmc.gov.il · 972-4-9107619

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Research on Gut Microbiota and Metabolomics in Diabetic Kidney Disease

Diabetic Nephropathy Type 2 · Type 2 Diabetes Mellitus (T2DM) · Chronic Kidney Disease

Abroad (travel likely)Recruiting

Changsha, China

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

Obesity · Overweight · Diabetes Mellitus, Type 2

Abroad (travel likely)RecruitingPHASE2

Gilbert, United States · Phoenix, United States

Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus · T2DM

Abroad (travel likely)RecruitingPHASE2

Mesa, United States · Orlando, United States

Evaluation of MTX-439 in Healthy Adults and Adults With Diabetic Kidney Disease

Healthy Adult Participants · Diabetic Kidney Disease

Abroad (travel likely)RecruitingPHASE1

Melbourne, Australia